Sage Therapeutics Statistics

Total Valuation

SAGE has a market cap or net worth of $478.94 million. The enterprise value is -$13.65 million.

Market Cap	478.94M
Enterprise Value	-13.65M

Important Dates

The next confirmed earnings date is Tuesday, April 29, 2025, after market close.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

SAGE has 61.48 million shares outstanding. The number of shares has increased by 1.55% in one year.

Current Share Class	61.48M
Shares Outstanding	61.48M
Shares Change (YoY)	+1.55%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	1.72%
Owned by Institutions (%)	67.02%
Float	49.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.48
Forward PS	6.10
PB Ratio	1.03
P/TBV Ratio	1.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.03.

Current Ratio	7.42
Quick Ratio	7.22
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.37% and return on invested capital (ROIC) is -40.04%.

Return on Equity (ROE)	-63.37%
Return on Assets (ROA)	-35.90%
Return on Invested Capital (ROIC)	-40.04%
Return on Capital Employed (ROCE)	-86.31%
Revenue Per Employee	$116,836
Profits Per Employee	-$1.14M
Employee Count	353
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.00% in the last 52 weeks. The beta is 0.48, so SAGE's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-40.00%
50-Day Moving Average	7.52
200-Day Moving Average	7.43
Relative Strength Index (RSI)	56.31
Average Volume (20 Days)	1,211,770

Short Selling Information

The latest short interest is 4.17 million, so 6.77% of the outstanding shares have been sold short.

Short Interest	4.17M
Short Previous Month	4.26M
Short % of Shares Out	6.77%
Short % of Float	8.46%
Short Ratio (days to cover)	3.22

Income Statement

In the last 12 months, SAGE had revenue of $41.24 million and -$400.67 million in losses. Loss per share was -$6.59.

Revenue	41.24M
Gross Profit	-194.10M
Operating Income	-410.52M
Pretax Income	-445.67M
Net Income	-400.67M
EBITDA	-409.49M
EBIT	-410.52M
Loss Per Share	-$6.59

Full Income Statement

Balance Sheet

The company has $504.42 million in cash and $11.84 million in debt, giving a net cash position of $492.58 million or $8.01 per share.

Cash & Cash Equivalents	504.42M
Total Debt	11.84M
Net Cash	492.58M
Net Cash Per Share	$8.01
Equity (Book Value)	465.09M
Book Value Per Share	7.58
Working Capital	459.69M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-267.19M
Capital Expenditures	n/a
Free Cash Flow	-267.19M
FCF Per Share	-$4.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-995.36%
Pretax Margin	-971.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SAGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.55%
Shareholder Yield	-1.55%
Earnings Yield	-83.66%
FCF Yield	-55.79%

Dividend Details

Analyst Forecast

The average price target for SAGE is $9.88, which is 27.16% higher than the current price. The consensus rating is "Hold".

Price Target	$9.88
Price Target Difference	27.16%
Analyst Consensus	Hold
Analyst Count	19
Revenue Growth Forecast (5Y)	41.27%
EPS Growth Forecast (5Y)	-41.21%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SAGE has an Altman Z-Score of -3.41 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.41
Piotroski F-Score	1